title: [The therapeutic efficacy of reaferon in meningoencephalitis].
abstract: There have been under observation 63 patients with meningoencephalitis at the age of 15-52 years whose complex treatment included reaferon and 42 patients with the same disease who were not given the drug. Reaferon was noted to be effective in meningoencephalitis. It shortened the period of clinical manifestation of the disease, hastened sanation of the liquor, influenced beneficially interferon production and modulated activity of the natural killers.
authors.forename: A F
authors.initials: AF
authors.lastname: Frolov
authors.forename: E K
authors.initials: EK
authors.lastname: Trinus
authors.forename: L V
authors.initials: LV
authors.lastname: Muravskaia
authors.forename: V V
authors.initials: VV
authors.lastname: Kononenko
authors.forename: O V
authors.initials: OV
authors.lastname: Novikova
authors.forename: S T
authors.initials: ST
authors.lastname: Diadiun
authors.forename: I A
authors.initials: IA
authors.lastname: Petrovskaia
authors.forename: L Ia
authors.initials: LIa
authors.lastname: Kushko
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D008297:Male; D008590:Meningoencephalitis / Q000134:cerebrospinal fluid / Q000276:immunology / Q000628:therapy*; D008875:Middle Aged; D011994:Recombinant Proteins; D012074:Remission Induction; D014777:Virus Diseases / Q000134:cerebrospinal fluid / Q000276:immunology / Q000628:therapy*
chemical_list: D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
vernacular_title: Terapevticheskaia éffektivnost' reaferona pri meningoéntsefalite.